Moxifloxacin Hydrochloride

盐酸莫西沙星

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameMoxifloxacin Hydrochloride
Drug Alias Name盐酸莫昔沙星盐酸利福喷丁VigamoxiVigamoxVegamox +[23] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsAcute BronchitisComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infections +[55] 
Global Approved IndicationsAcute BronchitisCommunity Acquired PneumoniaWound Infection +[12] 
Approved Indications in ChinaSinusitisPneumoniaBronchitis, Chronic +[5] 
Original Approved Country/TerritoryGermany
Original Approved Date1999/06/21
Country/TerritoryBelgiumBulgariaCanada +[51] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of KarachiHongShan Investment Management (Tianjin) Co LtdHarrow Health Inc +[14] 
Inactive CompaniesWashington University School Of MedicineOhsu Knight Cancer InstituteAlcon +[21] 
Active IndicationsAcute BronchitisCataractBronchiectasis +[15] 
Inactive IndicationsComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infectionsCommunity Acquired Pneumonia +[40] 

Other Information

ATC CodeJ01MA14S01AE07
Related LinksWikipediaDrugBankKEGG